https://naveris.com/ 2026-10-05T16:21:00+00:00 https://naveris.com/naveris-announces-medicare-coverage-of-the-navdx-test-in-anal-cancer-molecular-residual-disease-surveillance/ 2026-06-29T23:07:52+00:00 https://naveris.com/naveris-announces-expansion-of-the-navdx-test-in-anal-cancer-molecular-residual-disease-surveillance/ 2026-06-29T23:07:53+00:00 https://naveris.com/naveris-announces-expanded/ 2026-06-29T23:07:54+00:00 https://naveris.com/naveris-presents-new-data/ 2026-06-29T23:07:55+00:00 https://naveris.com/naveris-to-showcase-advances/ 2026-06-29T23:07:55+00:00 https://naveris.com/new-multicenter-study-highlights-use-of-the-navdx-test-in-resolving-clinically-indeterminate-findings/ 2026-06-29T23:07:56+00:00 https://naveris.com/naveris-to-present-new-data-highlighting-clinical-utility-of-the-navdx-test-at-the-2024-asco-annual-meeting/ 2026-06-29T23:07:57+00:00 https://naveris.com/naveris-announces-launch-of-phase-ii-clinical-study-in-mrd-head-and-neck-cancer/ 2026-06-29T23:07:58+00:00 https://naveris.com/naveris-announces-new-data-at-eurogin-international-multidisciplinary-hpv-congress-2024/ 2026-06-29T23:07:59+00:00 https://naveris.com/naveris-awarded-adlt-status-by-cms-for-the-navdx-test/ 2026-06-29T23:07:59+00:00 https://naveris.com/naveris-unveils-navigate-hpv-a-groundbreaking-registry-to-advance-hpv-driven-cancer-diagnosis-and-treatment/ 2026-06-29T23:08:00+00:00 https://naveris.com/naveris-announces-new-data-at-astro-multidisciplinary-head-and-neck-cancers-symposium-2024/ 2026-06-29T23:08:01+00:00 https://naveris.com/naveris-announces-commercial-payor-coverage-for-navdx-test-from-highmark-inc/ 2026-06-29T23:08:02+00:00 https://naveris.com/naveris-receives-medicare-coverage-for-navdx-test/ 2026-06-29T23:08:07+00:00 https://naveris.com/naveris-announces-two-peer-review-publications-validating-navdx-performance-in-daily-clinical-practice/ 2026-06-29T23:08:08+00:00 https://naveris.com/naveris-announces-new-data-featuring-navdx-in-oral-highlight-and-poster-presentations-at-upcoming-astro-and-aao-hnsf-2023-meetings/ 2026-06-29T23:08:09+00:00 https://naveris.com/mayo-clinic-collaborates-with-naveris-to-advance-precision-medicine-in-hpv-driven-head-and-neck-cancer-with-navdx-in-dart-2-0-clinical-trial/ 2026-06-29T23:08:10+00:00 https://naveris.com/naveris-collaborators-present-award-winning-abstract-at-astro-2022-on-potential-of-navdx-to-inform-treatment-strategies-in-hpv-driven-cancers/ 2026-06-29T23:08:11+00:00 https://naveris.com/naveris-announces-abstract-accepted-for-presentation-at-the-2022-american-society-for-clinical-oncology-asco-annual-meeting/ 2026-06-29T23:08:12+00:00 https://naveris.com/naveris-inc-raises-51-million-to-advance-commercialization-of-navdx/ 2026-06-29T23:08:12+00:00 https://naveris.com/naveris-head-and-neck-cancer-recurrence-detection-study-selected-for-presentation-at-astro-2022-plenary-session-2/ 2026-06-29T23:08:13+00:00 https://naveris.com/new-saliva-test-detects-head-and-neck-cancer/ 2026-06-29T23:08:14+00:00 https://naveris.com/naveris-inc-raises-19-million-in-financing-to-advance-and-commercialize-blood-tests-for-early-detection-of-hpv-and-other-viral-related-cancers-i/ 2026-06-29T23:08:14+00:00 https://naveris.com/naveris-congratulates-scientific-advisors-bhisham-chera-and-gaorav-gupta-on-presentation-of-clinical-data-at-the-2018-astro-annual-meeting-2/ 2026-06-29T23:08:15+00:00 https://naveris.com/blood-test-accurately-identifies-hpv-related-head-and-neck-cancer-recurrence-prospective-clinical-study-published-in-journal-of-clinical-oncology/ 2026-06-29T23:08:15+00:00 https://naveris.com/naveris-to-highlight-new-publications-at-the-44th-annual-j-p-morgan-healthcare-conference/ 2026-07-23T14:34:46+00:00 https://naveris.com/jim/ 2026-08-12T19:32:13+00:00 https://naveris.com/mark/ 2026-08-12T19:33:28+00:00 https://naveris.com/matt-what-it-means-to-confront-cancer-with-clarity-confidence-and-without-regrets/ 2026-08-12T19:34:15+00:00 https://naveris.com/case-study-detecting-mrd/ 2026-08-12T22:05:31+00:00